Active Internal Sequestration Service of CAR-T Potentiating RNA (Exo-Load)

Online Inquiry

Background Service What We Can Offer Workflow Highlights FAQs Contact

Conventional CAR-T development is often hindered by high manufacturing costs, reliance on viral vectors, limited in vivo persistence, and poor delivery efficiency for nucleic acid payloads. Creative Biolabs' Active Internal Sequestration of CAR-T Potentiating RNA (Exo-Load) service addresses these challenges through a proprietary exosome engineering platform that actively loads functional CAR-enhancing RNAs into biocompatible extracellular vesicles. This approach combines active sequestration with surface-functionalized targeting to enable efficient, cell-type-specific delivery without the complexities of viral systems. By streamlining manufacturing and supporting both ex vivo and in vivo applications, we provide scalable, off-the-shelf solutions that accelerate the development of next-generation cell therapies.

Introduction

The Exo-Load platform leverages exosomes as natural nanocarriers to enable efficient and biocompatible delivery of nucleic acid payloads for immunotherapeutic applications. By employing active internal sequestration, this approach actively loads CAR-potentiating RNA into exosomes, achieving targeted, sustained modulation of the tumor microenvironment to enhance CAR-T cell function without the complexities associated with viral or synthetic delivery systems.

Fig.1 Active intracellular sequestration of CAR-T enhancing RNA using exo-load. (Creative Biolabs Original) Fig.1 Exosome-mediated active sequestration of RNA for CAR-T potentiation.

Our Service

Our Active Internal Sequestration of CAR-T Potentiating RNA (Exo-Load) service is a proprietary exosome engineering platform that actively loads functional RNAs into biocompatible vesicles for precise immune cell programming. By enabling targeted, non-viral delivery and supporting both ex vivo and in vivo applications, it streamlines manufacturing, reduces toxicity risks, and accelerates the development of next-generation cell therapies.

What We Can Offer

We offer a comprehensive suite of engineered exosome platforms that enable active RNA loading, targeted delivery, and in situ immune cell programming, providing scalable solutions for next-generation CAR-T manufacturing and in vivo cell therapy development.

Featured services of precision CAR-protein enrichment & exosomal sorting technology at Creative Biolabs. (Creative Biolabs Original)

Our Service Process

Required Starting Materials:

To initiate the Exo-Load process, clients typically provide either the digital sequence of the potentiating RNA or pre-synthesized RNA constructs. Additionally, if specific cell-type targeting is required, information regarding the target surface markers must be provided.

Key Steps:

Workflow of precision CAR-protein enrichment & exosomal sorting technology at Creative Biolabs. (Creative Biolabs Original)

Final Deliverables: You will receive a detailed analytical characterization report, the functional potency data set, and the engineered exosome product.

Key Advantages

Localized Immunomodulation: The system achieves on-site delivery of potentiating RNA to tumor-resident cells, ensuring that CAR-T enhancing signals are produced precisely within the tumor microenvironment rather than systemically.
Reduced Systemic Toxicity: By confining RNA expression to locally sequestered cells, the approach minimizes off-target exposure to potent immunostimulatory molecules, thereby lowering the risk of cytokine release syndrome and other systemic adverse events.
Counteraction of T-Cell Exhaustion: The sustained, local supply of supportive cytokines and co-stimulatory signals directly within the tumor bed helps maintain CAR-T cell proliferation, persistence, and cytotoxic function, effectively mitigating exhaustion, a major limitation of current CAR-T therapies.

FAQs

Q1: Can I use Exo-Load for multiple types of RNA?

A1: Yes. The Exo-Load platform is designed to accommodate a broad range of RNA species, including mRNA, circRNA, siRNA, and miRNA. The sequestration mechanism is fine-tuned based on the molecular weight, secondary structure, and biochemical properties of each cargo, ensuring efficient loading and functional delivery across diverse RNA formats.

Q2: What is the shelf-life of the loaded exosomes?

A2: Loaded exosomes maintain long-term stability for over 12 months when stored under optimized conditions, either at -80°C or in our proprietary lyophilized formulation. Both preservation methods are validated to retain vesicle integrity and protect RNA cargo from degradation, ensuring consistent biological activity upon reconstitution or thawing.

Why Choose Us

Drawing on deep expertise in exosome engineering and immunotherapy, our Exo-Load platform leverages active sequestration to preserve exosomal integrity and enhance biocompatibility. This approach supports next-generation in vivo CAR-T strategies, enabling systemic delivery without reliance on toxic lymphodepletion.

Customer Reviews

"Incorporating Creative Biolabs' Exo-Load platform into our studies has greatly improved the delivery of circRNA to exhausted T cells. In our hands, the RNA exhibited substantially prolonged stability when compared against conventional LNP-based delivery systems." Dr. Al***n S.

"The active sequestration mechanism enabled by the Exo-Load service allowed us to achieve markedly higher knockdown efficiency specifically within the tumor microenvironment. Unlike passive loading methods, this approach ensured precise internal packaging and effectively eliminated the off-target RNA leakage that previously compromised our experiments." Prof. Ma***a K.

"Creative Biolabs delivered a highly streamlined process, taking us directly from custom sequence design to a fully characterized exosome product. By adopting the Exo-Load platform in our immunotherapy trials, we were able to completely avoid the safety concerns typically associated with viral vectors while maintaining robust experimental throughput." Dr. R***rt H.

How to contact us?

To explore how our Exo-Load platform can accelerate your CAR-T programs, please contact our scientific team. We are ready to discuss your custom RNA payloads, targeting strategies, and project timelines. Reach out via email or our online inquiry form to request a detailed quote and begin your collaboration.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.